Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Snowden

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|January 7, 1999
A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritisJ A Snowden, J C Biggs, S T Milliken, et al.
Clinical and Laboratory Haematology|June 1, 1997
The Rhnull phenotype in an English individual: haematological, serological and immunological studiesJ A Snowden, J Poole, A J Bates, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 11, 2008
Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemiaR Krishna, Y Sorour, J R Goepel, et al.
British Journal of Cancer|July 30, 2009
Follow-up care for cancer survivors: the views of cliniciansD M Greenfield, K Absolom, C Eiser, et al.
British Journal of Cancer|July 30, 2009
Follow-up care for cancer survivors: views of the younger adultK Absolom, C Eiser, G Michel, et al.
British Journal of Haematology|December 19, 1998
Composition and function of peripheral blood stem and progenitor cell harvests from patients with severe active rheumatoid arthritisJ A Snowden, V Nink, M Cooley, et al.
Arthritis and Rheumatism|March 20, 1998
Long-term outcome of autoimmune disease following allogeneic bone marrow transplantationJ A Snowden, P Kearney, A Kearney, et al.
Bone Marrow Transplantation|November 21, 2019
Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)P Tappenden, Y Wang, B Sharrack, et al.
Bone Marrow Transplantation|July 6, 2017
Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmesP D E Miller, T I de Silva, R Skinner, et al.
International Journal of Laboratory Hematology|April 26, 2013
United Kingdom Myeloma Forum (UKMF) position statement on the use of bendamustine in myelomaG Pratt, S Bowcock, M Lai, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|January 7, 1999
A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritisJ A Snowden, J C Biggs, S T Milliken, et al.
Clinical and Laboratory Haematology|June 1, 1997
The Rhnull phenotype in an English individual: haematological, serological and immunological studiesJ A Snowden, J Poole, A J Bates, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 11, 2008
Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemiaR Krishna, Y Sorour, J R Goepel, et al.
British Journal of Cancer|July 30, 2009
Follow-up care for cancer survivors: the views of cliniciansD M Greenfield, K Absolom, C Eiser, et al.
British Journal of Cancer|July 30, 2009
Follow-up care for cancer survivors: views of the younger adultK Absolom, C Eiser, G Michel, et al.
British Journal of Haematology|December 19, 1998
Composition and function of peripheral blood stem and progenitor cell harvests from patients with severe active rheumatoid arthritisJ A Snowden, V Nink, M Cooley, et al.
Arthritis and Rheumatism|March 20, 1998
Long-term outcome of autoimmune disease following allogeneic bone marrow transplantationJ A Snowden, P Kearney, A Kearney, et al.
Bone Marrow Transplantation|November 21, 2019
Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)P Tappenden, Y Wang, B Sharrack, et al.
Bone Marrow Transplantation|July 6, 2017
Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmesP D E Miller, T I de Silva, R Skinner, et al.
International Journal of Laboratory Hematology|April 26, 2013
United Kingdom Myeloma Forum (UKMF) position statement on the use of bendamustine in myelomaG Pratt, S Bowcock, M Lai, et al.
Pageof 10